Oral probiotics for infantile colic

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 3, 2014, Pages

  Praveen, Vijayakumar ^a   Praveen, Shama ^b   Deshpande, Girish ^c   Patole, Sanjay K ^d  

^a Department of Gastroenterology Mountain View Regional Hospital   (United States)

^b Pediatrix Medical Group   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHAMOMILE; CULTURELLE; DICOFLOR; FENNEL EXTRACT; FIORILAC; FLORASTOR; GLUCOSE; PLACEBO; PLANT EXTRACT; PROBIOTIC AGENT; REUTERIN; SIMETHICONE; SUCROSE; UNCLASSIFIED DRUG;

APPARENT LIFE THREATENING EVENT; ARTICLE; ARTIFICIAL MILK; BIFIDOBACTERIUM; CLINICAL PROTOCOL; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FENNEL; HERBAL TEA; HUMAN; INFANTILE COLIC; LACTOBACILLUS; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SHORT BOWEL SYNDROME; SUPPLEMENTATION; SYSTEMATIC REVIEW; TETRACYCLINE RESISTANCE; VANCOMYCIN RESISTANCE;

EID: 85019571277     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010986     Document Type: Article

References (95)

1. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 2011, Issue 3. [DOI: 10.1002/14651858.CD005496.pub3].
2. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs 2006;66(8):1073-88.
3. Baldassarre ME, Laforgia N, Fanelli M, Laneve A, Grosso R, Lifschitz C. Lactobacillus GG improves recovery in infants with blood in the stools and presumptive allergic colitis compared with extensively hydrolyzed formula alone. Journal of Pediatrics 2010;156(3):397-401.
4. Bongaerts GP, Tolboom JJ, Naber AH, Sperl WJ, Severijnen RS, Bakkeren JA, et al.Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microbial Pathogenesis 1997;22(5):285-93.
5. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M. Safety of probiotics that contain lactobacilli or bifidobacteria. Clinical Infectious Diseases 2003;36(3):775-80.
6. Boyle RJ, Robins-Browne RM, Tang ML. Probiotic use in clinical practice: what are the risks?. American Journal of Clinical Nutrition 2006;83(6):1256-64.
7. Broughton RA, Gruber WC, Haffar AA, Baker CJ. Neonatal meningitis due to Lactobacillus. Pediatric Infectious Disease 1983;2(5):382-4.
8. Bruni FM, Piacentini GL, Peroni DG, Bodini A, Fasoli E, Boner AL. Cow's milk allergic children can present sensitisation to probiotics. Acta Paediatricia 2009;98(2):321-3.
9. Council for Agricultural Science and Technology. Probiotics: their potential to impact human health. www.cast-science.org/publications/?probiotics_their_potential_to_impact_human_health&show=product&productID=2930 2010 (accessed 21 October 2013).
10. Cohen EA, Hadash A, Shehadeh N, Pillar G. Breastfeeding may improve nocturnal sleep and reduce infantile colic: potential role of breast milk melatonin. European Journal of Pediatrics 2012;171(4):729-32.
11. Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutrition and Cancer 2005;51(1):102-9.
12. Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L, et al.Probiotics and immune response. American Journal of Gastroenterology 2000;95(1 Suppl):S22-5.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
14. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010;125(5):921-30.
15. Deshpande G, Rao S, Patole S. Progress in the field of probiotics: year 2011. Current Opinion in Gastroenterology 2011;27(1):13-8.
16. Dobson D, Lucassen PLBJ, Miller JJ, Vlieger AM, Prescott P, Lewith G. Manipulative therapies for infantile colic. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD004796.pub2].
17. Donner A, Koval JJ. The estimation of intraclass correlation in the analysis of family data. Biometrics 1980;36(1):19-23.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
19. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vaillancourt JM. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
20. Falony G, Vlachou A, Verbrugghe K, De Vuyst L. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Applied and Environmental Microbiology 2006;72(12):7835-41.
21. Food, Agriculture Organization of the United Nations. World Health Organization. Guidelines for the evaluation of probiotics in food. www.fda.gov/ohrms/dockets/dockets/95s0316/95s-0316-rpt0282-tab-03-ref-19-joint-faowho-vol219.pdf 2010 (accessed 21 October 2013).
22. Freedman SB, Al-Harthy N, Thull-Freedman J. The crying infant: diagnostic testing and frequency of serious underlying disease. Pediatrics 2009;123(3):841-8.
23. Freeman PR. The performance of the two-stage analysis of two-treatment, two-period cross-over trials. Statistics in Medicine 1989;8(12):1421-32.
24. Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Imputing response rates from means and standard deviations in meta-analyses. International Clinical Psychopharmacology 2005;20(1):49-52.
25. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. American Journal of Gastroenterology 2010;105(7):1636-41.
26. Garrison MM, Christakis DA. A systematic review of treatments for infant colic. Pediatrics 2000;106(1Pt 2):184-90.
27. Gavaghan DJ, Moore AR, McQay HJ. An evaluation of homogeneity tests in meta-analysis in pain using simulations of patient data. Pain 2000;85(3):415-24.
28. Gill HS, Rutherford KJ. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. British Journal of Nutrition 2001;85(2):285-9.
29. Guandalini S, Pensabene L, Zikri MA. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoea: a multicenter European trial. Journal of Pediatric Gastroenterology and Nutrition 2000;30(1):54-60.
30. Gupta SK. Is colic a gastrointestinal disorder?. Current Opinion in Pediatrics 2002;14(5):588-92.
31. Ha GY, Yang CH, Kim H, Chong Y. Case of sepsis caused by Bifidobacterium longum. Journal of Clinical Microbiology 1999;37(4):1227-8.
32. He F, Morita H, Hashimoto H, Hosoda M, Kurisaki J, Ouwehand AC, et al.Intestinal Bifidobacterium species induce varying amounts of cytokine production. Journal of Allergy and Clinical Immunology 2002;109(6):1035-6.
33. Heine RG. Allergic gastrointestinal motility disorders in infancy and early childhood. Pediatric Allergy and Immunology 2008;19(5):383-91.
34. Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JNV, Suttorp MJ, et al.Safety of probiotics to reduce risk and prevent or treat disease. www.ncbi.nlm.nih.gov/books/NBK56091/ 2011 (accessed 20 November 2013).
35. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
36. Higgins JPT, Thompson SG, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557.
37. Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008:243-96.
38. Higgins JPT, Deeks JJ. Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
39. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
41. Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clinical Infectious Diseases 1997;25(5):1048-55.
42. Iacono G, Merolla R, D'Amico D, Bonci E, Cavataio F, Di Prima L, et al.Gastrointestinal symptoms in infancy: a population-based prospective study. Digestive and Liver Disease 2005;37:432-8.
43. Jenke A, Ruf EM, Hoppe T, Heldmann M, Wirth S. Bifidobacterium septicaemia in an extremely low-birthweight infant under probiotic therapy. Archives of Disease in Childhood. Fetal Neonatal Edition 2012;97(3):217-8.
44. Kalima P, Masterton RG, Roddie PH, Thomas AE. Lactobacillus rhamnosus infection in a child following bone marrow transplant. Journal of Infection 1996;32(2):165-7.
45. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357(9262):1076-9.
46. Keefe MR, Kajrisen KA, Lobo ML, Kotzer AM, Dudley WN. Reducing parenting stress in families with irritable infants. Nursing Research 2006;55(3):198-205.
47. Kirjavainen PV, ElNezami HS, Salminen SJ, Ahokas JT, Wright PF. Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation. Clinical and Diagnostic Laboratory Immunology 1999;6(6):790-802.
48. Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008;121(4):e850-6.
49. Kopp MV, Salfeld P. Probiotics and prevention of allergic disease. Current Opinion in Clinical Nutrition and Metabolic Care 2009;12(3):298-303.
50. Ku WH, Lau DC, Huen KF. Probiotics provoked D-lactic acidosis in short bowel syndrome: case report and literature review. Hong Kong Journal of Paediatrics 2006;11:246-54.
51. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. Journal of Pediatric Gastroenterology and Nutrition 2004;38(4):457-8.
52. Kunze WA, Mao YK, Wang B, Huizinga JD, Ma X, Forsythe P, et al.Lactobacillus reuteri enhances excitability of colonic AH neurons by inhibiting calcium dependent potassium channel opening. Journal of Cellular and Molecular Medicine 2009;13(8B):2261-70.
53. Larsen CN, Nielsen S, Kæstel P, Brockmann E, Bennedsen M, Christensen HR, et al.Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. European Journal of Clinical Nutrition 2006;60(11):1284-93.
54. Lucassen PL, Assendelft WJ, Gubbels JW, Van Eijk JT, Douwes AC. Infantile colic: crying time reduction with a whey hydrolysate: a double-blind, randomized, placebo-controlled trial. Pediatrics 2000;106(6):1349-54.
55. Lucassen PL, Assendelft WJ, Van Eijk JT, Gubbels JW, Douwes AC, Van Geldrop WJ. Systematic review of the occurrence of infantile colic in the community. Archives of Disease in Childhood 2001;84(5):398-403.
56. Luyer MD, Buurman WA, Hadfoune M. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infection and Immunity 2005;73(6):3686-92.
57. Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze W. Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. American Journal of Physiology Gastrointestinal and Liver Physiology 2009;296(4):G868-75.
58. Martín-Muñoz MF, Fortuni M, Caminoa M, Belver T, Quirce S, Caballero T. Anaphylactic reaction to probiotics. Cow's milk and hen's egg allergens in probiotic compounds. Pediatric Allergy Immunology 2012;23(8):778-84.
59. Munakata S, Arakawa C, Kohira R, Fujita Y, Fuchigami T, Mugishima H. A case of D-lactic acid encephalopathy associated with use of probiotics. Brain and Development 2010;32(8):691-4.
60. Ohishi A, Takahashi S, Ito Y, Ohishi Y, Tsukamoto K, Nanba Y, et al.Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. Journal of Pediatrics 2010;156(4):679-81.
61. Pedone CA, Bernabeu AO, Postaire ER, Bouley CF, Reinert P. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. International Journal of Clinical Practice 1999;53(3):179-84.
62. Perapoch J, Planes AM, Querol A, López V, Martínez-Bendayán I, Tormo R, et al.Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura. European Journal of Clinical Microbiology and Infectious Diseases 2000;19(6):468-70.
63. Perry R, Hunt K, Ernst E. Nutritional supplements and other complementary medicines for infantile colic: a systematic review. Pediatrics 2011;127(4):720-33.
64. Petschow BW, Figueroa R, Harris CL, Beck LB, Ziegler E, Goldin B. Effects of feeding an infant formula containing Lactobacillus GG on the colonization of the intestine: a dose-response study in healthy infants. Journal of Clinical Gastroenterology 2005;39(9):786-90.
65. Prescott SL, Wiltschut J, Taylor A, Westcott L, Jung W, Currie H, et al.Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008;63(11):1481-90.
66. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, et al.Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clinical Infectious Diseases 1999;28(5):1159-60.
67. Reddy VS, Patole SK, Rao S. Role of probiotics in short bowel syndrome in infants and children - a systematic review. Nutrients 2013;5(3):679-99.
68. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
69. Rhoads JM, Fatheree NY, Norori J, Liu Y, Lucke JF, Tyson JE, et al.Altered fecal microflora and increased fecal calprotectin in infants with colic. Journal of Pediatrics 2009;155(6):823-8.
70. Roberfroid M. Prebiotics: the concept revisited. Journal of Nutrition 2007;137(3 Suppl 2):830-7S.
71. Roberts DM, Ostapchuk M, O'Brien JG. Infant colic. American Family Physician 2004;70(4):735-40.
72. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance plasmids from Lactobacillus reuteri ATCC 55 730 and characterization of the resulting daughter strain, L reuteri DSM 17 938. Applied and Environmental Microbiology 2008;74(19):6032-40.
73. Saavedra JM. Probiotics plus antibiotics: regulating our bacterial environment. Journal of Pediatrics 1999;135(5):535-7.
74. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, et al.Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clinical Infectious Diseases 2002;35(10):1155-60.
75. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, et al.Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clinical Infectious Diseases 2004;38(1):62-9.
76. Savino F, Cresi F, Pautasso S, Palumeri E, Tullio V, Roana J, et al.Intestinal microflora in breastfed colicky and non-colicky infants. Acta Paediatrica 2004;93(6):825-9.
77. Savino F, Bailo E, Oggero R, Tullio V, Roana J, Carlone N, et al.Bacterial counts of intestinal Lactobacillus species in infants with colic. Pediatric Allergy and Immunology 2005;18(1):72-5.
78. Savino F, Grassino EC, Guidi C, Oggero R, Silvestro L, Miniero R. Ghrelin and motilin concentration in colicky infants. Acta Paediatrica 2006;95(6):738-41.
79. Savino F. Focus on infantile colic. Acta Paediatrica 2007;96(9):1259-64.
80. Savino F, Pelle E, Castagno E, Palumeri E, Oggero R. Must infants with colic really be hospitalized?. Acta Paediatrica 2007;96(7):1109.
81. Savino F, Cordisco L, Tarasco V, Calabrese R, Palumeri E, Matteuzzi D. Molecular identification of coliform bacteria from colicky breast-fed infants. Acta Paediatrica 2009;98(10):1582-8.
82. Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, et al.Lactobacillus reuteri DSM 17938 in infant colic: a randomized, double-blind, placebo controlled trial. Pediatrics 2010;126(3):e526-33.
83. Savino F, Tarasco V, Lingua C, Moja L, Ricceri F. Pain-relieving agents for infant colic. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD009999].
84. Savino F, Tarasco V, Sorrenti M, Lingua C, Moja L, Gordon, M, et al.Dietary modifications for infantile colic. Cochrane Database of Systematic Reviews In press.
85. Soleman N, Laferl H, Kneifel W, Tucek G, Budschedl E, Weber H, et al.How safe is safe? A case of Lactobacillus paracasei ssp. paracasei endocarditis and discussion of the safety of lactic acid bacteria. Scandinavian Journal of Infectious Diseases 2003;35(10):759-62.
86. Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008:297-333.
87. Stifter CA, Bono MA. Effect of infant colic on maternal self-perceptions and mother-infant bonding. Child: Care Health and Development 1998;24(5):339-51.
88. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology 2007;119(1):184-91.
89. Thomas DW, Greer FR, Committee on Nutrition. Probiotics and prebiotics in pediatrics. Pediatrics 2010;126(6):1217-31.
90. Thompson C, McCarter YS, Krause PJ, Herson VC. Lactobacillus acidophilus sepsis in a neonate. Journal of Perinatology 2001;21(4):258-60.
91. Tynkkynen S, Singh KV, Varmanen P. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. International Journal of Food Microbiology 1998;41(3):195-204.
92. Vanderhoof JA, Young RJ, Murray N, Kaufman SS. Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition 1998;27(2):155-60.
93. Walter J, Britton RA, Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proceedings of the National Academy of Sciences of the United States of America 2011;108(Suppl 1):4645-52.
94. Wang B, Mao YK, Diorio C, Wang L, Huizinga JD, Bienenstock J, et al.Lactobacillus reuteri ingestion and IK(Ca) channel blockade have similar effects on rat colon motility and myenteric neurones. Neurogastroenterology and Motility 2010;22(1):98-107.
95. Wessel MA, Cobb JC, Jackson EB, Harris GS Jr, Detwiler AC. Paroxysmal fussing in infancy, sometimes called "colic". Pediatrics 1954;14(5):421-35.